Author: Ross Keith

Plague or anthrax on the subway? Think again, says now-corrected study

Cell SystemsAuthors of a widely covered study that documented traces of plague and anthrax on surfaces across New York City have revised the paper after public health officials challenged their interpretations of the data.

It’s hard to overestimate the attention these findings received when first published.

“Bubonic plague found in NYC subway,” wrote The Daily Beast.

“Your subway seat mate: Bubonic plague, anthrax, & mysterious DNA,” said Yahoo!

“NY subway has bubonic plague,” declared Newser.

Not so fast. In an erratum published July 29, the authors write: Continue reading Plague or anthrax on the subway? Think again, says now-corrected study

Inquiry into duplications reveals “multiple” image problems in tumor study

STEM_17_1.c1.inddA paper on how abnormal stem cells can cause benign bone tumors has been retracted by Cell Stem Cell after an inquiry into image duplications also uncovered “multiple instances of inappropriate western blot image adjustment.”

The first two authors “declined” to sign the retraction, according to the notice.

Besides confirming initial suspicions that images had been duplicated, the editors also found “multiple instances of inappropriate western blot image adjustment, such as uneven compression of images and removal of background elements:”

Continue reading Inquiry into duplications reveals “multiple” image problems in tumor study

Voinnet notches second retraction, two more corrections

PNASOlivier Voinnet — a plant researcher who was recently suspended for two years from the Centre national de la recherche scientifique (CNRS) after an investigation by ETH Zurich and CNRS found evidence of misconduct — has issued his second retraction and two more corrections.

PNAS posted the retraction earlier this week for a 2006 article after an inspection of the raw data revealed “errors” in study images. Authors confirmed the issues in some figures and revealed “additional mounting mistakes” in others.

Voinnet has promised to issue retractions and corrections for every study that requires them. These latest notices bring our tally up to nine corrections, two retractions and one Expression of Concern.

Continue reading Voinnet notches second retraction, two more corrections

Retracting duplicated paper “may damage the integrity of the literature,” says plant journal editor

In Vitro Cellular & Developmental Biology - PlantIn Vitro Cellular & Developmental Biology – Plant has flagged a 2004 article that was “accidentally” duplicated from another paper published earlier that year — but did so in the form of a publisher’s erratum, not a retraction.

The editor of the journal justified the decision by arguing that the duplicated paper had been cited “over a dozen times” and was old enough to not warrant a retraction:

Considering that both articles were published over a decade ago and both have been referenced by other papers over a dozen times each, it seems like a retraction of one manuscript may damage the integrity of the literature more than using the erratum to point out the error to future scientists.

The study, “In vitro shoot regeneration from cotyledonary node explants of a multipurpose leguminous tree, Pterocarpus marsupium roxb,” developed a protocol for effectively growing shoots of the Indian Kino tree.

The first version has been cited 21 times and the duplicated version was cited 13 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice:

Continue reading Retracting duplicated paper “may damage the integrity of the literature,” says plant journal editor

“Falsified” data shelve two more drug studies from discredited U Colorado student

The authors of a pair of papers in Molecular Pharmaceutics are retracting them following an investigation at the University of Colorado Denver, which found a graduate student had faked data.

Rajendra Kadam was a prominent member of the Research lab of Uday B. Kompella, until the investigation revealed earlier this year that he had “falsified” data from a liquid chromatography-mass spectroscopy (LC-MS) machine for years.

So far, we’ve found four retractions (including the latest two) and one expression of concern for Kadam. There may be more on the way: Continue reading “Falsified” data shelve two more drug studies from discredited U Colorado student

UPitt investigation brings total retraction count to four for pair of cancer researchers

Journal of Biological Chemistry1An official inquiry by the University of Pittsburgh has led to two more retractions for a pair of cancer researchers, Tong Wu and Chang Han. By our count, the pair now have four retractions under their belt, all the result of the university investigation.

The Journal of Biological Chemistry published the notices earlier this month, after it was discovered the papers contained cropped panels, among other issues. Importantly, the two papers appear to even have shared some data.

One 2006 paper, “Modulation of Stat3 Activation by the Cytosolic Phospholipase A2α and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway,” investigated the molecular actors in cancer growth, such as overexpression of cyclooxygenase-2 (COX-2). It has been cited 34 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice:

Continue reading UPitt investigation brings total retraction count to four for pair of cancer researchers

Head of major diagnostic lab in Canada steps down amid investigation

AJPA_v185_i7_COVER.inddA prominent endocrinologist pathologist has resigned from running the largest hospital diagnostic laboratory in Canada following an investigation that has uncovered evidence of falsified data in two papers, Retraction Watch has learned.

Sylvia Asa was the Program Medical Director of the Laboratory Medicine Program at the University Health Network, affiliated with the University of Toronto, until this past spring when she stepped down, according to UHN spokesperson Gillian Howard:

Continue reading Head of major diagnostic lab in Canada steps down amid investigation

Author’s ties to NFL lead to correction for review that cast doubt on brain risk from sports

PLOS ONE

A review paper that suggested the degenerative brain disease that’s striking former football players may not be tied to contact sports has been corrected to reveal the first author spent decades working for the National Football League.

The correction appears in a review in PLOS ONE about chronic traumatic encephalopathy – the degenerative brain disease that was the basis of a $765 million settlement for former NFL players, along with a number of similar lawsuits. It fixes incorrect statements and adds conflicts of interest, including those with with first author Joseph Maroon, who spent more than 30 years working with the NFL and seven for the wrestling group the WWE.

It appears as if all the original paper declared was that Maroon was an “unpaid consultant” to the Pittsburgh Steelers. But apparently there was a lot more to it, according to the notice:

Continue reading Author’s ties to NFL lead to correction for review that cast doubt on brain risk from sports

Second correx for controversial paper on the financial benefits of climate change

Journal of Economic PerspectivesThe Journal of Economic Perspectives has published a second correction for a 2009 paper that argued that some amount of global warming could lead to economic gains.

The author of “The Economic Effects of Climate Change,” Richard Tol, a professor of economics at the University of Sussex, blamed earlier problems with the paper on “gremlins.” In a notice posted last year, Tol wrote that “minus signs were dropped”; he also added a pair of “overlooked estimates” and several recently published studies.

After the first correction was published, several people contacted the JEP to point out more issues with the paper. Editors worked with Tol and outside researchers to update the paper again.

Here’s some text from the newest correction notice:

Continue reading Second correx for controversial paper on the financial benefits of climate change

Duke lung researcher up to seven retractions

Enviromental Health Perspectives

More journals have pulled papers co-authored by researchers Erin Potts-Kant and Michael Foster, at Duke University, bringing the total up to seven for Potts-Kant and six for Foster.

Authors were unable to replicate the experiments after “concerns about the initial data from the animal physiology laboratory” led them to reanalyze source data, according to the note in Environmental Health Perspectives. The comparison showed “potential inconsistencies in the data,” which “significantly impact the overall conclusions of the manuscript.” Similar issues appear to have felled the pair’s other papers, including the other two recent retractions in the American Journal of Respiratory and Critical Care Medicine and the American Journal of Physiology – Lung Cellular and Molecular Physiology — but in the latter case, the discrepancies don’t affect the conclusion.

Potts-Kant was arrested on embezzlement charges in 2013. Authorities alleged that she stole almost $15,000 from Duke University.

Environmental Health Perspectives posted a retraction in July, for a 2012 paper that looked at the molecular underpinnings in airways that react to ozone.

Here’s the full notice:

Continue reading Duke lung researcher up to seven retractions